319 related articles for article (PubMed ID: 15780522)
1. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
[TBL] [Abstract][Full Text] [Related]
2. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
5. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
Lakoski SG; Herrington DM
Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
[TBL] [Abstract][Full Text] [Related]
7. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
9. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
13. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
[TBL] [Abstract][Full Text] [Related]
15. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.
Crandall C; Palla S; Reboussin B; Hu P; Barrett-Connor E; Reuben D; Greendale G
J Womens Health (Larchmt); 2006; 15(1):14-23. PubMed ID: 16417414
[TBL] [Abstract][Full Text] [Related]
17. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
18. Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.
Ziakas A; Gavrilidis S; Souliou E; Giannoglou G; Stiliadis I; Karvounis H; Efthimiadis G; Mochlas S; Vayona MA; Hatzitolios A; Savopoulos C; Pidonia I; Parharidis G
Angiology; 2009; 60(1):50-9. PubMed ID: 18388036
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
20. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
